Group 1: Research Basic Information - The research object is Youningwei, belonging to the professional services industry, with a reception time of August 4, 2025. The listed company's reception staff includes Deputy General Manager and Board Secretary Qi Yanfang, and Securities Affairs Representative Xia Qingli [17] Group 2: Detailed Research Institutions - The reception objects include Huitong Fund (a fund management company) and Tianling Investment (an investment company) [18] Group 3: Main Content Information - The company is a one - stop service provider in life sciences, offering products and services such as reagents, consumables, instruments, and laboratory services. It currently has a product structure with agency products as the main part and self - owned brand products as a supplement. In 2024, the total revenue of self - owned brand products increased by nearly 30% year - on - year [22] - The overall gross margin of the company's self - owned brand is about 50%, and the revenue is expected to increase in proportion as the company invests more in sales resources and enriches product pipelines [22] - In 2024, the company launched a share repurchase plan, using 25,987,076 yuan of its own funds to repurchase 927,600 shares for equity incentives or employee stock ownership plans, and will launch relevant plans according to business development [22] - The company's business is mainly in the domestic market. It will accelerate the overseas expansion of self - owned brand products based on R & D and domestic sales, and established a company in Singapore in 2024. It also promotes products through online and offline means [22][23] - The company will strengthen channel and R & D capabilities around the "Two Extremes Strategy". In terms of external expansion, it will seek investment and cooperation with potential upstream and downstream target enterprises with synergistic effects, mainly product - type companies related to antibody applications [23]
优宁维分析师会议-20250804